SIGA Technologies, Inc.

NASDAQ:SIGA

Drug Manufacturers - Specialty & Generic

Healthcare
$2.80 -0.36%

-$0.02 today

Market cap
$201.19M
Beta
0.85
P/E (TTM)
15.2
EPS (TTM)
$0.28
Dividend yield
13.97%
52W Low $4.10High $9.62

Volume 0.37M

Average 0.61M

SIGA Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

SIGA Technologies, Inc.NASDAQ: SIGA

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue declines year over year

Q1 FY2026 revenue of $6.24M fell 11.3% year over year, ahead of the -22.1% change in trailing-twelve-month revenue. Sequentially, it rose 64.3% from the prior quarter. Over 3 fiscal years it compounded at -5.1% a year.

Context

  • Revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of $53.55M (-43.4%) for the fiscal year ending Dec 2026, a slowdown from the -31.8% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.24M+64.3% QoQ
Last fiscal yearDec 2025
$94.6M-31.8% YoY
LTMMar 2026
$93.78M-22.1% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.3%——
1 year-31.8%-43.4%-11.6 pp
3-year CAGR-5.1%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
94.6M USD
Year-over-year change
-31.8%
4-year CAGR
-8.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How SIGA compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -22.1% is the 6th highest of 9, against a peer median of -3.1%.
  • Over three fiscal years its annual growth of -5.1% compares with a peer median of +8.8%.
SIGA Competitors
Revenue for SIGA and competitors
Company Period LTM YoY 3-year CAGR
SNDLSNDL Inc.LTM Mar 2026CA$937.39M CAD+1.1%+9.9%
EBSEmergent BioSolutions Inc.LTM Mar 2026$676.8M USD-29.9%-12.7%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026$513.57M USD+11.9%+7.7%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$418.24M USD+61.1%+74.8%
RIGLRigel Pharmaceuticals, Inc.LTM Mar 2026$299.77M USD+47.6%+34.8%
SIGASIGA Technologies, Inc.LTM Mar 2026$93.78M USD-22.1%-5.1%
AQSTAquestive Therapeutics, Inc.LTM Mar 2026$50.27M USD-7.3%-2.2%
CTMXCytomX Therapeutics, Inc.LTM Mar 2026$35.54M USD-75.9%+12.8%
DRIODarioHealth Corp.LTM Mar 2026$21.19M USD-24.4%-6.8%
OLMAOlema Pharmaceuticals, Inc.LTM Mar 2026$0 USD——
Peer median (excluding SIGA) —-3.1%+8.8%

Competitors are the stored peer set for SIGA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue133.67M110.78M139.92M138.72M94.6M
Cost of Revenue16.6M10.43M17.83M31.29M29.7M
Gross Profit117.07M100.34M122.09M107.43M64.87M
Gross Margin87.6%90.6%87.3%77.4%68.6%
Research & Development9.94M22.53M16.43M12.31M6.53M
Selling, General & Admin18.03M35.12M22.04M25.14M3.13M
Operating Expenses27.98M57.64M38.47M37.45M41.17M
Depreciation & Amortization522.37K517.64K538.29K538.42K562.61K
EBITDA89.83M44.65M88.31M76.61M30.96M
EBITDA Margin67.2%40.3%63.1%55.2%32.7%
Operating Income89.09M42.7M83.62M69.98M23.7M
Operating Margin66.7%38.5%59.8%50.4%25.1%
Interest Income00006.68M
Interest Expense00000
Other Income / Expenses218.94K1.43M4.16M6.09M6.7M
Income Before Tax89.31M44.13M87.78M76.07M30.4M
Pre-Tax Margin66.8%39.8%62.7%54.8%32.1%
Income Tax Expense19.86M10.23M19.71M16.86M7.1M
Net Income69.45M33.9M68.07M59.21M23.3M
Net Margin52.0%30.6%48.6%42.7%24.6%
EPS (Basic)0.920.460.950.830.33
EPS (Diluted)0.910.460.950.830.33
Weighted Avg Shares75.32M72.93M71.36M71.25M71.6M
Weighted Avg Shares (Diluted)76.4M73.55M71.68M71.77M71.6M

SIGA Technologies, Inc.

NASDAQ:SIGA

Intrinsic Alpha fair value

Locked

Current Price

$2.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.